<DOC>
	<DOCNO>NCT01197001</DOCNO>
	<brief_summary>Study Design : - A single center , open , randomize , single dose , two-period , two-treatment , two-sequence , crossover study Primary Objective : - To assess bioequivalence combination oral formulation amlodipine/losartan versus two co-administered product contain amlodipine losartan</brief_summary>
	<brief_title>A Bioequivalence Study Amlodipine Plus Losartan Versus Amlodipine Losartan</brief_title>
	<detailed_description>Secondary Objective : - To evaluate safety tolerability formulation .</detailed_description>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Age 1855 year Healthy Caucasian volunteer Non smoker mild smoker Exclusion criterion : Pregnancy and/or breastfeed Participation another clinical trial within 60 day prior Period 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Amlodipine , Losartan</keyword>
</DOC>